FAQs concerning the visual inspection of Parenterals
The issue manual versus fully automatic inspection with regard to a 100% visual inspection of parenterals is a frequently discussed GMP issue. Please find a list of Q&As on this subject in our GMP News Read more.
Discussion of elemental Impurities in pharmaceutical Water
The question arose if pharmaceutical water need to comply to the requirements of USP <232> with regard to elemental impurities, especially if water is the main component of a medicinal product. These requirements are much more tighten than the traditional test on heavy metals (pb) which has been replaced by the conductivity measurement. Read more.
Cross-contamination: Topic of the Revisions of Chapters 3 and 5 EU GMP Guideline
The revisions of the chapters 3 and 5 of the EU GMP Guideline published in January concern exclusively the topic cross-contamination and the measures aimed at minimising the risk of cross-contamination. Read more.
New EMA Guideline on Dedicated Facilities and Exposure Limits for Cleaning Validation
The European Medicines Agency (EMA) published the long-awaited draft of the Guideline on setting health based exposure limits in January 2013. This has an impact on the limits to be observed in the cleaning validation and on the requirements on shared/multipurpose or dedicated facilities. Read more.
EMA publishes Concept Paper on Dedicated / Shared Facilities
In October, the European Medicines Agency published a new Concept Paper which has been developed by the Safety Working Group together with the GMP/GDP Inspectors Working Group. The document focuses on the establishment of an harmonised risk identification with toxicological data. Read more.
Results of the Survey "Implementation of the new Annex 1 requirements for Capping"
Concept Heidelberg started a European survey about the implementation of the requirements to Annex 1 for Vial Capping in 2010 . You can find the first results here.